Transplantation

1-7 of 7

• 

  RestartResume

  Axatilimab for cGVHD: Assessing Organ-Specific Responses in AGAVE-201

  RestartResume

  Axatilimab for cGVHD: Assessing Organ-Specific Responses in AGAVE-201

  Project Oncology®

  Axatilimab for cGVHD: Assessing Organ-Specific Responses in AGAVE-201

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Shernan Holtan, MD

  • 

    

    Alicia Lieberman, MD, MS

• 

  RestartResume

  Chronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies

  RestartResume

  Chronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies

  Project Oncology®

  Chronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies

  • 

    

    Brian P. McDonough, MD, FAAFP

  • 

    

    Doris M. Ponce, MD, MS

• 

  RestartResume

  Evaluating Axatilimab in Chronic GVHD: How Prior Therapies Impact Outcomes

  RestartResume

  Evaluating Axatilimab in Chronic GVHD: How Prior Therapies Impact Outcomes

  Project Oncology®

  Evaluating Axatilimab in Chronic GVHD: How Prior Therapies Impact Outcomes

  • 

    

    Hallie Blevins, PhD.

• 

  RestartResume

  Evaluating Patient and Clinician-Reported Responses to Axatilimab in cGVHD

  RestartResume

  Evaluating Patient and Clinician-Reported Responses to Axatilimab in cGVHD

  Project Oncology®

  Evaluating Patient and Clinician-Reported Responses to Axatilimab in cGVHD

  • 

    

    Brian P. McDonough, MD, FAAFP

  • 

    

    Christopher Graham, MD

• 

  RestartResume

  Managing Chronic Graft-Versus-Host Disease with CSF1R Inhibition

  RestartResume

  Managing Chronic Graft-Versus-Host Disease with CSF1R Inhibition

  Project Oncology®

  Managing Chronic Graft-Versus-Host Disease with CSF1R Inhibition

  • 

    

    Jennifer Caudle, DO

  • 

    

    Andrew Harris, MD

• 

  RestartResume

  Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease

  RestartResume

  Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease

  Clinician's Roundtable

  Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease

• 

  RestartResume

  Hepatocellular Carcinoma: Clinical Priorities from Detection to Liver Transplantation

  RestartResume

  Hepatocellular Carcinoma: Clinical Priorities from Detection to Liver Transplantation

  Medical Breakthroughs from Penn Medicine

  Hepatocellular Carcinoma: Clinical Priorities from Detection to Liver Transplantation

  • 

    

    Barnett Mennen, MD

  • 

    

    Maarouf Hoteit, MD